Canlyniadau Chwilio - Einar Smith

  • Dangos 1 - 8 canlyniadau o 8
Mireinio'r Canlyniadau
  1. 1
    Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes

    Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes gan Filip Ottosson, Einar Smith, Olle Melander, Céline Fernandez

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Plasma Metabolites Associate with All-Cause Mortality in Individuals with Type 2 Diabetes

    Plasma Metabolites Associate with All-Cause Mortality in Individuals with Type 2 Diabetes gan Filip Ottosson, Einar Smith, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes

    Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes gan Filip Ottosson, Einar Smith, Widet Gallo, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease

    Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease gan Einar Smith, Filip Ottosson, Sophie Hellstrand, Ulrika Ericson, Marju Orho‐Melander, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease

    The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease gan Filip Ottosson, Louise Brunkwall, Einar Smith, Marju Orho‐Melander, Peter M. Nilsson, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease

    A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease gan Einar Smith, Ulrika Ericson, Sophie Hellstrand, Marju Orho‐Melander, Peter M. Nilsson, Céline Fernandez, Olle Melander, Filip Ottosson

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality

    Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality gan Filip Ottosson, Ulrika Ericson, Peter Almgren, Einar Smith, Louise Brunkwall, Sophie Hellstrand, Peter M. Nilsson, Marju Orho‐Melander, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality

    Metabolome-Defined Obesity and the Risk of Future Type 2 Diabetes and Mortality gan Filip Ottosson, Einar Smith, Ulrika Ericson, Louise Brunkwall, Marju Orho‐Melander, Salvatore Di Somma, Paola Antonini, Peter M. Nilsson, Céline Fernandez, Olle Melander

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: